Roche is launching a new genomic profiling kit that lets cancer researchers explore tumors without having to send tissue samples to centralized laboratories, the Swiss drugmaker said on Oct. 25.
Avantor will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up the U.S. lab products provider’s Covid-19 therapy and vaccine manufacturing operations.
The University of Oxford is testing the anti-parasitic drug ivermectin as a possible treatment for Covid-19, as part of a British government-backed study that aims to aid recoveries in non-hospital settings.
Top U.S. infectious disease expert Dr. Anthony Fauci called on China to release the medical records of nine people whose ailments might provide vital clues into whether Covid-19 first emerged as the result of a lab leak, the Financial Times reported on June 3.
The U.S. intelligence community on May 27 acknowledged its agencies had two theories on where the coronavirus originated, with two agencies believing it emerged naturally from human contact with infected animals and a third embracing a possible laboratory accident as the source of the Covid-19 pandemic.
President Joe Biden ordered aides to find answers to the origin of the virus that causes Covid-19, saying on May 26 that U.S. intelligence agencies are pursuing rival theories potentially including the possibility of a laboratory accident in China.
Nearly two-thirds of people tested in India have shown exposure to Covid-19, a chain of private laboratories said on May 19, indicating a runaway spread of the virus as the daily death toll rose to a record 4,529.
Abbott on March 11 announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
Shares of bluebird bio climbed in trading after the company announced on March 10 that analyses demonstrate the lentiviral vector BB305 was unlikely to be the cause of acute myeloid leukemia (AML) reported in an early-stage clinical study of LentiGlobin for sickle cell disease.
Laboratory testing found that Regeneron Pharmaceuticals Inc.’s Covid-19 antibody cocktail can combat a coronavirus variant first found in South Africa, but a similar drug from Eli Lilly and Co. is inactive against it, according to a study.